IM+ Capitals Ltd
BSE:511628
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IM+ Capitals Ltd
BSE:511628
|
IN |
|
H
|
Hubei Goto Biopharm Co Ltd
SZSE:300966
|
CN |
|
Duni AB
STO:DUNI
|
SE |
Income Statement
Earnings Waterfall
IM+ Capitals Ltd
Income Statement
IM+ Capitals Ltd
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
68
N/A
|
65
-4%
|
66
+1%
|
77
+16%
|
60
-21%
|
52
-13%
|
48
-8%
|
42
-14%
|
42
+2%
|
43
+2%
|
37
-14%
|
31
-16%
|
25
-21%
|
20
-19%
|
217
+981%
|
460
+112%
|
1 154
+151%
|
1 750
+52%
|
3 524
+101%
|
5 152
+46%
|
5 259
+2%
|
4 124
-22%
|
3 135
-24%
|
4 252
+36%
|
3 606
-15%
|
3 290
-9%
|
3 199
-3%
|
|
| Gross Profit | ||||||||||||||||||||||||||||
| Cost of Revenue |
(20)
|
(18)
|
(15)
|
(13)
|
(7)
|
(7)
|
(5)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(186)
|
(439)
|
(972)
|
(1 504)
|
(3 042)
|
(4 125)
|
(4 202)
|
(3 303)
|
(2 820)
|
(3 777)
|
(3 282)
|
(3 022)
|
(2 919)
|
|
| Gross Profit |
47
N/A
|
47
+0%
|
51
+7%
|
63
+24%
|
53
-16%
|
37
-31%
|
35
-4%
|
31
-12%
|
40
+27%
|
40
+1%
|
34
-14%
|
28
-19%
|
20
-28%
|
16
-22%
|
31
+95%
|
20
-34%
|
181
+787%
|
246
+36%
|
481
+96%
|
1 027
+113%
|
1 057
+3%
|
821
-22%
|
314
-62%
|
474
+51%
|
324
-32%
|
268
-17%
|
281
+5%
|
|
| Operating Income | ||||||||||||||||||||||||||||
| Operating Expenses |
(26)
|
(26)
|
(26)
|
(32)
|
(40)
|
(38)
|
(45)
|
(38)
|
(17)
|
(15)
|
(6)
|
(8)
|
(11)
|
(11)
|
(9)
|
(27)
|
(171)
|
(223)
|
(384)
|
(534)
|
(543)
|
(499)
|
(376)
|
(314)
|
(371)
|
(263)
|
(267)
|
|
| Selling, General & Administrative |
(11)
|
(11)
|
(11)
|
(12)
|
(9)
|
(8)
|
(6)
|
(6)
|
(4)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(4)
|
(6)
|
(5)
|
(9)
|
(3)
|
(3)
|
(283)
|
(10)
|
(11)
|
(14)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(8)
|
(12)
|
(21)
|
(20)
|
(25)
|
(27)
|
(24)
|
(21)
|
(22)
|
(33)
|
(36)
|
(39)
|
(42)
|
|
| Other Operating Expenses |
(15)
|
(14)
|
(15)
|
(19)
|
(30)
|
(29)
|
(38)
|
(32)
|
(12)
|
(11)
|
(2)
|
(4)
|
(8)
|
(7)
|
(1)
|
(13)
|
(147)
|
(199)
|
(353)
|
(502)
|
(511)
|
(475)
|
(352)
|
2
|
(325)
|
(213)
|
(211)
|
|
| Operating Income |
21
N/A
|
22
+3%
|
25
+13%
|
31
+27%
|
14
-56%
|
7
-46%
|
(2)
N/A
|
1
N/A
|
23
+1 999%
|
25
+12%
|
28
+11%
|
20
-28%
|
9
-56%
|
5
-46%
|
21
+347%
|
(6)
N/A
|
10
N/A
|
23
+122%
|
97
+329%
|
493
+405%
|
514
+4%
|
322
-37%
|
(62)
N/A
|
161
N/A
|
(47)
N/A
|
5
N/A
|
14
+168%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
2
|
2
|
2
|
(8)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(41)
|
0
|
0
|
157
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
15
|
18
|
13
|
69
|
151
|
148
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
195
|
0
|
0
|
11
|
0
|
0
|
0
|
|
| Total Other Income |
1
|
1
|
1
|
1
|
2
|
9
|
11
|
11
|
12
|
(1)
|
(2)
|
0
|
5
|
4
|
54
|
95
|
190
|
245
|
505
|
514
|
270
|
284
|
279
|
48
|
331
|
277
|
602
|
|
| Pre-Tax Income |
22
N/A
|
23
+3%
|
25
+12%
|
32
+26%
|
15
-53%
|
19
+26%
|
12
-37%
|
15
+25%
|
28
+84%
|
24
-12%
|
26
+9%
|
21
-22%
|
14
-34%
|
9
-37%
|
76
+782%
|
88
+17%
|
200
+127%
|
267
+34%
|
603
+125%
|
1 007
+67%
|
952
-5%
|
621
-35%
|
235
-62%
|
390
+66%
|
353
-9%
|
433
+23%
|
764
+76%
|
|
| Net Income | ||||||||||||||||||||||||||||
| Tax Provision |
(6)
|
(6)
|
(7)
|
(9)
|
(4)
|
(5)
|
(3)
|
(4)
|
(11)
|
(10)
|
(11)
|
(9)
|
(4)
|
(3)
|
(2)
|
(1)
|
7
|
1
|
(10)
|
(13)
|
(15)
|
(11)
|
(4)
|
(13)
|
(13)
|
(18)
|
(22)
|
|
| Income from Continuing Operations |
16
|
16
|
18
|
23
|
11
|
14
|
9
|
11
|
17
|
14
|
16
|
11
|
10
|
6
|
74
|
88
|
207
|
268
|
593
|
994
|
937
|
610
|
231
|
377
|
340
|
415
|
742
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Equity Earnings Affiliates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
16
N/A
|
16
+3%
|
18
+14%
|
23
+27%
|
11
-54%
|
14
+29%
|
9
-35%
|
11
+25%
|
17
+51%
|
14
-15%
|
16
+9%
|
11
-27%
|
10
-16%
|
6
-41%
|
74
+1 187%
|
88
+19%
|
207
+137%
|
268
+29%
|
592
+121%
|
993
+68%
|
940
-5%
|
610
-35%
|
232
-62%
|
377
+63%
|
340
-10%
|
415
+22%
|
742
+79%
|
|
| EPS (Diluted) |
4.47
N/A
|
4.63
+4%
|
5.27
+14%
|
6.68
+27%
|
3.09
-54%
|
3.98
+29%
|
2.57
-35%
|
3.21
+25%
|
4.85
+51%
|
4.11
-15%
|
4.46
+9%
|
3.27
-27%
|
2.76
-16%
|
1.65
-40%
|
21.27
+1 189%
|
25.61
+20%
|
5.92
-77%
|
37.69
+537%
|
66.41
+76%
|
111.31
+68%
|
10.26
-91%
|
5.5
-46%
|
1.56
-72%
|
2.54
+63%
|
1.69
-33%
|
2.07
+22%
|
3.67
+77%
|
|